Oser Communications Group

Chain Drugstore Daily NACD Aug 12 2013

Issue link: http://osercommunicationsgroup.uberflip.com/i/265897

Contents of this Issue

Navigation

Page 25 of 71

C h a i n D r u g s t o r e D a i l y M o n d a y, A u g u s t 1 2 , 2 0 1 3 2 6 UNIWEB BELIEVES IN TEAMWORK Uniweb goes beyond simply providing fixtures – it partners with store and phar- macy operations to meet the retailers' challenges as a team. Forty-plus years of experience allows the company to share the best practices to achieve the model that meets all the requirements. Uniweb productivity-enhancing products and reliable support services help clients work efficiently, while creating and beautifying space. Uniweb works with your staff and architects to design the pharmacy's exte- rior and/or interior to meet your compa- ny's specific aesthetic requirements, including surface options, materials, cus- tom colors, and finishes to coordinate with your surrounding store interiors. Together, these elements help to create a welcoming ambiance for both customers and staff to enjoy. The sales team provides an analyti- cal approach, looking at existing condi- tions and desired objectives. Each mem- ber of the sales team is a veteran in the study of time and motion, applying these principles to measure workflow and look for areas for improvement. This is a crit- ical step in the process to achieve an increase in workflow/productivity, but not increase the company's footprint. The sales team collaborates with the store design and pharmacy team to develop a "rough" draft of the proposed layout. Uniweb's design team evaluates the proposed draft, runs it through a series of models, assesses it to see if the objectives are met, and adjusts accordingly, until all goals are reached. Uniweb's production team manu- factures the project components in a fully-integrated factory using the best processes available. Factory-built pre- cision is guaranteed with Uniweb's state-of-the-industry 180,000 sq. ft. manufacturing facility. Uniweb's millwork team allows customers to get their products from one location, saving time, consolidating communications, and, most importantly, saving money! Uniweb's project man- agement team coordinates the delivery and installation of the project. All projects install in 3-5 days – a space goes from bare floor to occu- pied in 3-5 days! Functionality and Style The Uniweb solution is based on factory- built modular units, allowing for total flexibility of the complete unit and/or all above and below accessories. Given that Uniweb is a custom manufacturer, it is not limited to "fixed" boxes or compo- nents. This allows for every square foot of space to be fully utilized! The Uniweb experience has proven that it can increase pharmacy inventory capacity by 30 percent and offer project costs 15-20 percent less than conventional mill- work solutions. Add to this the tax advantage of depreciating the complete project as a "fixture"– and this accelerates the return of investment. Uniweb integrates their custom trim pack- ages to keep your store's look fresh and modern. Along with the appealing trim styles, Uniweb can illuminate your feature products by coordinating LED lighting with Uniweb's patented storage systems. Many design possibilities are available: custom metal finishes, trim strips, décor panels, laminates, wood and wood veneers, dry wall facings, decora- tive metals, glass, tile, awnings, special lighting, signage, and many others. For more information, visit booth 2112, call 800-486-4932 or visit www .uniwebinc.com. SUN PHARMA USA: MAKING A MARK WITH COMPLEX TECHNOLOGY, DIFFERENTIATED PRODUCTS By Steven Goodman, Director of Marketing-Generics We began our U.S. foray in 1997, when we first took a stake in Caraco, which then had sales of less than $1 million and a few approvals. Since then, we've built up a substantial business in the US, and now it contributes to more than half of our business. Last year's con- solidated U.S. revenues were over $ 1 billion, 54 percent of revenues, spurred partly by sales of unapproved Lipodox (Liposomal Doxorubicin nanoparticle injection) which we were allowed to sell with special permission in order to meet a Doxil shortage. Sun Pharma USA offers a range of high quality generics across dosage forms, with strong portfolios in controlled substances, anticancers. Recently we acquired URL Pharma (except for the Colcrys business) to strengthen our prod- uct basket. The acquisition of DUSA with its patented business (Levulan and Blue- light device) allows us to initiate a pres- ence in the dermatology device market. We believe the $70 billion U.S. generic market offers us a tremendous opportunity to bring to the patient, high quality pharmaceuticals made to exacting standards in USFDA-approved plants both in the United States and in India. Starting with simple dosage forms, tablets and capsules, our range has now grown to encompass differentiated prod- ucts like nanoparticle-based injections for targeted drug delivery, lyophilized injections, auto injections, controlled release products, etc. We're one of the few generic compa- nies that have manufacturing both in the U.S. and India. Starting with one Indian and one U.S. mainland USFDA- approved plant each in 1997, we now have six dosage form plants in the U.S., in addition to three plants in India that are USFDA-approved. Our Cranbury plant is designed to make controlled substance formulations. For API, we have three approved plants in India, in addition to a plant each in the U.S. (Chattem Chemicals) and Hungary. These plants are designed, built, and run to stringent USFDA requirements. Our ability to develop processes and make in-house API for complex products such as peptides, controlled substances and hormones, ensures we not only use the best quality API, but are also amongst the most efficient producers. An experienced and skilled regulato- ry team ensures dossiers are comprehen- sive and good quality. Corporate Quality teams support technically proficient teams at each of the plants; an independ- ent Corporate Compliance team ensures that all our factories and those of our ven- dors and suppliers, meet FDA norms. We have over 350 ANDAs approved, and over 138 await approval, with filings for complex products like nasal sprays, depot injections, and modi- fied release products. This is one of the strongest pipelines among Indian compa- nies. Every year we file around 20-plus ANDAs to replenish our pipeline. Across four world class research centers, over 800 scientists work on process and product development so that we're able to continually file for ANDA and API, and move up the scale in terms of complexity. A strong patent team works with our scientists to examine possibilities for non-infringing processes or science- based patent challenges. With clear plans for growth, we're keen to grow our U.S. presence and bring the customer high quality generics that can be trusted. For more information, visit booth 3615 or go online to www.caraco.com. SAFETY RX + QUANTROS PATIENT SAFETY CENTER: A PHARMACEUTICAL ADVANTAGE By Allison Snow, Executive Director, Quantros Patient Safety Center In a changing healthcare marketplace where both increased business pres- sures and more onerous government regulation mean heightened risk, phar- macies have had to align with and behave more like hospitals and health- care providers in ensuring patient safe- ty and minimizing risk. Hospital stan- dards are edging into convenience clin- ics and retail pharmacy chains, along- side an expectation for transparency, patient safety, and reliable quality. To stay ahead of safety and quality demands, pharmacies need Quantros. Specifically, they need Quantros Patient Safety Center and Safety Rx. Quantros Patient Safety Center (QPSC) is equipped with years of expertise built on hospital safety require- ments and customized to satisfy the needs of pharmacies. As a Patient Safety Organization (PSO), QPSC is legally- protected environment where healthcare organizations and pharmacies can col- lect, aggregate, and analyze data, there- by improving quality by identifying and reducing the risks and hazards associated with patient care. Today, QPSC is the only PSO that integrates with a safety reporting product designed for retail pharmacies, Quantros Safety Rx. Safety Rx, a Web-based solution for pharmacists and pharmacy staff to report safety and quality incidents, combines with the QPSC to optimize legal protection and patient safety. When deployed with QPSC, Safety Rx delivers an end-to-end solution which aggre- gates more data than other PSOs, thus optimiz- ing benchmarking capabilities, legal protection and patient safety. Unlike other products, Safety Rx was pur- pose-built for pharmacies and pharma- cy chains by Quantros, the industry pioneer and provider of software and service to advance quality and safety performance. Safety Rx enables phar- macies to: demonstrate compassion and quality care at a time when health- care performance, quality and safety are more transparent and of higher per- ceived value than ever; raise customer switching costs; and differentiate themselves by better protecting patients (and themselves). Combining Safety Rx with QPSC provides pharmacies the advantage of being ahead of what will soon be an industry standard for safety. In fact, some states already require pharmacies to par- ticipate in a PSO as part of continuous quality improvement compliance. PSO m e m b e r s h i p also offers the opportunity to c o l l a b o r a t e with peers on safety concerns without fear of disclosure outside PSO and the opportunity to compare safety perform- ance between chains themselves, as well as between chains and other pharmacy segments (inpatient, sub-acute, inde- pendent, etc.). Today, executives of pharmacies need a simple, yet smart, way to capture data on adverse events for quick analy- sis, reporting and remediation. Quantros is that way. We believe pharmacies are the most important provider of health- care for many Americans today, and they will only grow in prominence and acces- sibility. Together, we can create an industry that is safe for the patient, and safe for the pharmacy. For more information, visit booth 3145 at the NACDS Total Store Expo, go online to www.quantros.com, call 877-QUANTROS or email sales@quantros.com.

Articles in this issue

Links on this page

view archives of Oser Communications Group - Chain Drugstore Daily NACD Aug 12 2013